An LC-MS/MS procedure for the quantification of naproxen in human plasma: Development, validation, comparison with other methods, and application to a pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 879, Issue 19, 2011, Pages 1686-1696

  Elsinghorst, Paul W ^a,c,e   Kinzig, Martina ^a   Rodamer, Michael ^a   Holzgrabe, Ulrike ^b   Sörgel, Fritz ^a,d  

^a IBMP Institute for Biomedical and Pharmaceutical Research   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e Central Institute of the Bundeswehr Medical Service Munich   (Germany)

Author keywords

Liquid chromatography; Naproxen; Pharmacokinetics; Tandem mass spectrometry; Validation

Indexed keywords

BIOANALYTICAL ASSAYS; CONCENTRATION RANGES; HUMAN PLASMAS; INTERNAL STANDARDS; KETOPROFEN; LC-MS/MS; LOWER LIMIT OF QUANTITATIONS; NAPROXEN; NAPROXENS; PHARMACOKINETIC STUDIES; PROTEIN PRECIPITATION; RUNTIMES; SAMPLE PREPARATION; SIMULTANEOUS ACHIEVEMENT; TANDEM MASS SPECTROMETRY; VALIDATION;

ACETONITRILE; ASSAYS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

PHARMACOKINETICS;

ACETONITRILE; KETOPROFEN; NAPROXEN;

ACCURACY; ARTICLE; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STANDARD; VALIDATION STUDY;

CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HUMANS; KETOPROFEN; LINEAR MODELS; NAPROXEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 79955918510     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.04.012     Document Type: Article

References (72)

1. Brogden R.N., Pinder R.M., Sawyer P.R., Speight T.M., Avery G.S. Drugs 1975, 9:326.
2. Alshammary F., Azizmian N., Mian M. Anal. Prof. Drug Subst. 1992, 21:345.
3. Duggan K.C., Walters M.J., Musee J., Harp J.M., Kiefer J.R., Oates J.A., Marnett L.J. J. Biol. Chem. 2010, 285:34950.
4. Healy L.O., Murrihy J.P., Tan A., Cocker D., McEnery M., Glennon J.D. J. Chromatogr. A 2001, 924:459.
5. Segre E.J. J. Reprod. Med. 1980, 25:222.
6. Sutton L.B. J. Am. Pharm. Assoc. 1996, 36:663.
7. Vane J.R. Nat. N. Biol. 1971, 231:232.
8. Vane J.R., Bakhle Y.S., Botting R.M. Annu. Rev. Pharmacol. Toxicol. 1998, 38:97.
9. Botting R.M. J. Physiol. Pharmacol. 2006, 57:113.
10. Gajraj N.M. Anesth. Analg. 2003, 96:1720.
11. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., Day R., Ferraz M.B., Hawkey C.J., Hochberg M.C., Kvien T.K., Schnitzer T.J. N. Engl. J. Med. 2000, 343:1520.
12. Chakraborti A.K., Garg S.K., Kumar R., Motiwala H.F., Jadhavar P.S. Curr. Med. Chem. 2010, 17:1563.
13. Vonkeman H.E., van de Laar M.A.F.J. Semin. Arthritis Rheum 2010, 39:294.
14. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for industry: bioanalytical method validation, 2001.
15. U.S. Department of Health and Human Services, Food and Drug Administration, Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products - general considerations, 2003.
16. European Medicines Agency, Committee for Medicinal Products for Human Use, Guideline on validation of bioanalytical methods, 2009.
17. Runkel R., Chaplin M., Boost G., Segre E., Forchielli E. J. Pharm. Sci. 1972, 61:703.
18. Runkel R., Forchielli E., Boost G., Chaplin M., Hill R., Sevelius H., Thompson G., Segre E. Scand. J. Rheumatol. Suppl. 1973, 2:29.
19. Piafsky K.M., Borgå O. Clin. Pharmacol. Ther. 1977, 22:545.
20. Andersen J.V., Hansen S.H. J. Chromatogr. Biomed. Appl. 1992, 577:325.
21. Sultan M., Stecher G., Stöggl W.M., Bakry R., Zaborski P., Huck C.W., El Kousy N.M., Bonn G.K. Curr. Med. Chem. 2005, 12:573.
22. Miksa I.R., Cummings M.R., Poppenga R.H. J. Anal. Toxicol. 2005, 29:95.
23. van Loenhout J.W.A., van Ginneken C.A.M., Ketelaars H.C.J., Kimenai P.M., Tan Y., Gribnau F.W.J. J. Liq. Chromatogr. Relat. Technol. 1982, 5:549.
24. Zakeri-Milani P., Barzegar-Jalali M., Tajerzadeh H., Azarmi Y., Valizadeh H. J. Pharm. Biomed. Anal. 2005, 39:624.
25. Blagbrough I.S., Daykin M.M., Doherty M., Pattrick M., Shaw P.N. J. Chromatogr. Biomed. Appl. 1992, 578:251.
26. Marzo A., Monti N., Ripamonti M., Marzo P., Wool C., Cerutti R., Maggi G.C. Arzneimittelforschung 1997, 47:385.
27. Slattery J.T., Levy G. Clin. Biochem. 1979, 12:100.
28. Satterwhite J.H., Boudinot F.D. J. Chromatogr. Biomed. Appl. 1988, 431:444.
29. Levine B., Caplan Y.H. Clin. Chem. 1985, 31:346.
30. Broquaire M., Rovei V., Braithwaite R. J. Chromatogr. Biomed. Appl. 1981, 224:43.
31. Upton R.A., Buskin J.N., Guentert T.W., Williams R.L., Riegelman S. J. Chromatogr. 1980, 190:119.
32. Vree T.B., van den Biggelaar-Martea M., Verwey-van Wissen C.P. J. Chromatogr. Biomed. Appl. 1992, 578:239.
33. Streete P.J. J. Chromatogr. Biomed. Appl. 1989, 495:179.
34. Dusci L.J., Hackett L.P. J. Chromatogr. 1979, 172:516.
35. Aresta A., Palmisano F., Zambonin C.G. J. Pharm. Biomed. Anal. 2005, 39:643.
36. Hirai T., Matsumoto S., Kishi I. J. Chromatogr. Biomed. Appl. 1997, 692:375.
37. Lo D.S., Chao T.C., Ng-Ong S.E., Yao Y.J., Koh T.H. Forensic Sci. Int 1997, 90:205.
38. Shimek J.L., Rao N.G., Khalil S.K. J. Pharm. Sci. 1982, 71:436.
39. Burgoyne R.F., Brown P.R., Kaplan S.R. J. Liq. Chromatogr. Relat. Technol. 1980, 3:101.
40. Westerlund D., Theodorsen A., Jaksch Y. J. Liq. Chromatogr. Relat. Technol. 1979, 2:969.
41. Tashtoush B.M., Al-Taani B.M. Pharmazie 2003, 58:614.
42. Mikami E., Goto T., Ohno T., Matsumoto H., Nishida M. J. Pharm. Biomed. Anal. 2000, 23:917.
43. Larsen N.E., Marinelli K. J. Chromatogr. Biomed. Appl. 1981, 222:482.
44. Wan S.H., Matin S.B. J. Chromatogr. 1979, 170:473.
45. Weber S.S., Bankhurst A.D., Mroszczak E., Ding T.L. Ther. Drug Monit. 1981, 3:75.
46. Desager J.P., Vanderbist M., Harvengt C. J. Clin. Pharmacol. 1976, 16:189.
47. Mortensen A., Jensen E.B., Petersen P.B., Husted S., Andreasen F. Acta Pharmacol. Toxicol. 1979, 44:277.
48. Held H. J. Clin. Chem. Clin. Biochem. 1978, 16:579.
49. Anttila M. J. Pharm. Sci. 1977, 66:433.
50. Guermouche M.H., Atik N., Chader B. J. AOAC Int. 2000, 83:1489.
51. Abdel-Moety E.M., Al-Obaid A.M., Jado A.I., Lotfi E.A. Eur. J. Drug Metab. Pharmacokinet. 1988, 13:267.
52. Knie U. J. Chromatogr. Biomed. Appl. 1983, 275:463.
53. Phillips T.M., Wellner E.F. Biomed. Chromatogr. 2006, 20:662.
54. Albrecht C., Thormann W. J. Chromatogr. A 1998, 802:115.
55. Sun Y., Zhang Z., Xi Z., Shi Z. Talanta 2009, 79:676.
56. Kazemifard A.G., Moore D.E. J. Chromatogr. Biomed. Appl. 1990, 533:125.
57. Pérez-Ruiz T., Martínez-Lozano C., Tomás V., Carpena J. J. Pharm. Biomed. Anal. 1998, 17:719.
58. Nováková L., Vlcková H. Anal. Chim. Acta 2009, 656:8.
59. Jemal M. Biomed. Chromatogr. 2000, 14:422.
60. Niazi S.K., Alam S.M., Ahmad S.I. Biopharm. Drug Dispos. 1996, 17:355.
61. Anttila M., Haataja M., Kasanen A. Eur. J. Clin. Pharmacol. 1980, 18:263.
62. Caillé G., Du Souich P., Gervais P., Besner J.G. Biopharm. Drug Dispos. 1987, 8:173.
63. Caillé G., du Souich P., Besner J.G., Gervais P., Vézina M. Am. J. Med. 1989, 86:38.
64. Ling T.L., Yee J.P., Cohen A., Hsiao C., Gonzalez M.A., Garg D.C., Weidler D.J. J. Clin. Pharmacol. 1987, 27:325.
65. Ryley N.J., Lingam G. Curr. Med. Res. Opin. 1988, 11:10.
66. Strocchi E., Ambrosioni E., Palazzini E., Galli G. Int. J. Clin. Pharmacol. Ther. Toxicol. 1991, 29:253.
67. Vree T.B., van den Biggelaar-Martea M., Verwey-van Wissen C.P., Vree J.B., Guelen P.J. Biopharm. Drug Dispos. 1993, 14:491.
68. Zhou D., Zhang Q., Lu W., Xia Q., Wei S. J. Clin. Pharmacol. 1998, 38:625.
69. Dunagan F.M., McGill P.E., Kelman A.W., Whiting B. Br. J. Rheumatol. 1988, 27:48.
70. Runkel R., Chaplin M.D., Sevelius H., Ortega E., Segre E. Clin. Pharmacol. Ther. 1976, 20:269.
71. Segre E.J. J. Clin. Pharmacol. 1975, 15:316.
72. Charles B.G., Mogg G.A. Biopharm. Drug Dispos. 1994, 15:121.